These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition. Reginelli JP; Chew D J Interv Cardiol; 2002 Apr; 15(2):141-6. PubMed ID: 12063809 [No Abstract] [Full Text] [Related]
10. Role of tirofiban in the medical treatment of the intermediate-risk patient with an acute coronary syndrome cannot be denied. Goldberg L; Mekel J Am J Cardiol; 2000 Dec; 86(12):1401-2. PubMed ID: 11192745 [No Abstract] [Full Text] [Related]
11. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. Stone GW; Bertrand ME; Moses JW; Ohman EM; Lincoff AM; Ware JH; Pocock SJ; McLaurin BT; Cox DA; Jafar MZ; Chandna H; Hartmann F; Leisch F; Strasser RH; Desaga M; Stuckey TD; Zelman RB; Lieber IH; Cohen DJ; Mehran R; White HD; JAMA; 2007 Feb; 297(6):591-602. PubMed ID: 17299194 [TBL] [Abstract][Full Text] [Related]
12. [Standard pharmacological therapy associated with percutaneous coronary interventions in patients with stable angina]. Karcz M; Ruzyłło W Kardiol Pol; 2004 Nov; 61(11):480-2. PubMed ID: 15883598 [No Abstract] [Full Text] [Related]
13. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Fernandez JS; Sadaniantz A Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658 [No Abstract] [Full Text] [Related]
14. GP IIb/IIIa blockade during peripheral artery interventions. Tepe G; Wiskirchen J; Pereira P; Claussen CD; Miller S; Duda SH Cardiovasc Intervent Radiol; 2008; 31(1):8-13. PubMed ID: 17479207 [TBL] [Abstract][Full Text] [Related]
15. Platelet glycoprotein IIb/IIIa receptor blockade: lessening the risk of coronary interventions. Pitts WR; Lange RA Thromb Haemost; 1999 Sep; 82 Suppl 1():136-8. PubMed ID: 10695505 [TBL] [Abstract][Full Text] [Related]
16. Facilitated percutaneous coronary intervention: a novel concept in expediting and improving acute myocardial infarction care. Li RH; Herrmann HC Am Heart J; 2000 Dec; 140(6 Suppl):S125-35. PubMed ID: 11100006 [No Abstract] [Full Text] [Related]
17. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. Campbell P N Engl J Med; 2001 Nov; 345(21):1573-4; author reply 1574-5. PubMed ID: 11794228 [No Abstract] [Full Text] [Related]
19. Updated guidelines for percutaneous coronary intervention: what are the most important changes? Spencer BK; Smith SC Pol Arch Med Wewn; 2008 Mar; 118(3):96-7. PubMed ID: 18476453 [No Abstract] [Full Text] [Related]
20. Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven? Lincoff AM; Topol EJ Eur Heart J; 2000 Jun; 21(11):863-7. PubMed ID: 10806004 [No Abstract] [Full Text] [Related] [Next] [New Search]